Swiss Market Ends Flat After Lackluster Session

RTTNews | 34 hari yang lalu
Swiss Market Ends Flat After Lackluster Session

(RTTNews) - The Switzerland market ended flat on Thursday after a highly lackluster session as investors stayed reluctant to make significant moves amid a lack of fresh triggers.

The benchmark SMI ended with a marginal loss of 1.40 points at 11,230.43. The index, which advanced to 11,281.46 in early trades, dropped to a low of 11,173.64 around late afternoon before recovering some lost ground.

ABB gained about 6.3%. The stock rallied as the company reported higher Operational EBITA in its first quarter and sounded optimistic about faster revenue growth in 2024.

Sika, Givaudan and UBS Group gained 0.6 to 0.8%. Alcon and Geberit edged up marginally.

Partners Group dropped 3.26%, while Richemont and Lonza Group ended lower by 2.5% and 2.34%, respectively. Logitech International, Zurich Insurance Group, Swisscom, Swiss Life Holding and Novartis lost 0.4 to 0.7%.

In the Mid Price Index, Barry Callebaut rallied about 4.3%. Sandoz climbed 2.3% and Adecco gained about 2.25%. Lindt & Spruengli N, PSP Swiss Property, Schindler Holding, BKW, Lindt & Spruengli Part, Georg Fischer, Julius Baer, Temenos Group and Avolta gained 1 to 1.75%.

Tecan Group, ams OSRAM and VAT Group ended down 2.31%, 1.61% and 1.01%, respectively. Swatch Group and Straumann Holding ended modestly lower.

On the economic front, data from the Federal Customs Administration showed Switzerland's foreign trade surplus increased to CHF 8.6 billion in the first quarter, up from CHF 8.1 billion in the final quarter of 2023.

In real terms, exports rebounded 0.6%, following a 0.5% drop a quarter ago. At the same time, the decline in imports softened to 0.2% from 0.7%.

In March, the trade surplus rose to CHF 2.8 billion from CHF 2.3 billion in February, data showed. In real terms, exports and imports declined by 1.7% and 2.3%, respectively, from a month earlier.

Another report from the Federation of the Swiss Watch Industry showed that watch exports decreased sharply by 16.1% on a yearly basis to CHF 2.0 billion in March. As a result, the decrease for the first quarter as a whole was 6.3% compared with last year.

read more
U.S. Existing Home Sales Unexpectedly Extend Pullback In April

U.S. Existing Home Sales Unexpectedly Extend Pullback In April

Existing home sales in the U.S. unexpectedly saw further downside in the month of April, according to a report released by the National Association of Realtors on Wednesday. NAR said existing home sales slumped by 1.9 percent to an annual rate of 4.14 million in April after tumbling by 3.7 percent to a revised rate of 4.22 million in March.
RTTNews | 4h 34menit yang lalu
Hovnanian Enterprises Net Profit Rises 48.9%

Hovnanian Enterprises Net Profit Rises 48.9%

Homebuilder Hovnanian Enterprises Inc. (HOV) reported Wednesday that net income for the second quarter increased 48.9 percent to $50.8 million or $6.66 per share from $34.1 million or $4.47 per share in the prior-year quarter.
RTTNews | 4h 56menit yang lalu
Anglo American And BHP Major Shareholder PIC Demands Substantial Revision Of BHP Proposal For Anglo

Anglo American And BHP Major Shareholder PIC Demands Substantial Revision Of BHP Proposal For Anglo

Public Investment Corp. or PIC, a major shareholder of both Anglo American plc (AAUKY.PK, AAL.L) and BHP Group (BHP), on Wednesday said it requires a meaningful revision of the current BHP proposal for Anglo American to "reflect both the embedded value of existing Anglo assets and the future optionality and benefits that BHP can derive, specifically from Anglo's unlisted assets."
RTTNews | 5h 53menit yang lalu
Bay Street Likely To Open Lower

Bay Street Likely To Open Lower

Canadian shares are likely to open on a slightly negative note Wednesday morning as energy and materials sectors may find the going somewhat tough due to weak commodity prices.
RTTNews | 6h 42menit yang lalu
Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen Inc. (BIIB) and privately-held biotechnology company Human Immunology Biosciences or HI-Bio, announced Wednesday the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15 billion upfront and up to $650 million in potential milestone payments.
RTTNews | 6h 44menit yang lalu
UK Inflation Slows Less Than Expected To 2.3%

UK Inflation Slows Less Than Expected To 2.3%

UK consumer prices rose more than expected in April due to the stickiness of services inflation, which would possibly delay the timing of the first interest rate cut. Consumer prices rose 2.3 percent on a yearly basis in April, slower than the 3.2 percent increase in March, the Office for National Statistics reported Wednesday.
RTTNews | 6h 54menit yang lalu